Table of Contents

1 Study Coverage

• 1.1 Testosterone undecanoate Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Testosterone undecanoate Market Size Growth Rate by Product
  • 1.4.2 Injection
  • 1.4.3 Oral
• 1.5 Market by End User
  • 1.5.1 Global Testosterone undecanoate Market Size Growth Rate by End User
  • 1.5.2 Primary hypogonadism
  • 1.5.3 Hypogonadotropic hypogonadism
  • 1.5.4 Late-onset hypogonadism
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Testosterone undecanoate Market Size
  • 2.1.1 Global Testosterone undecanoate Revenue 2014-2025
  • 2.1.2 Global Testosterone undecanoate Sales 2014-2025
• 2.2 Testosterone undecanoate Growth Rate by Regions
  • 2.2.1 Global Testosterone undecanoate Sales by Regions
  • 2.2.2 Global Testosterone undecanoate Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Testosterone undecanoate Sales by Manufacturers
  • 3.1.1 Testosterone undecanoate Sales by Manufacturers
  • 3.1.2 Testosterone undecanoate Sales Market Share by Manufacturers
  • 3.1.3 Global Testosterone undecanoate Market Concentration Ratio (CR5 and HHI)
• 3.2 Testosterone undecanoate Revenue by Manufacturers
  • 3.2.1 Testosterone undecanoate Revenue by Manufacturers (2014-2019)
  • 3.2.2 Testosterone undecanoate Revenue Share by Manufacturers (2014-2019)
• 3.3 Testosterone undecanoate Price by Manufacturers
• 3.4 Testosterone undecanoate Manufacturing Base Distribution, Product Types
  • 3.4.1 Testosterone undecanoate Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Testosterone undecanoate Product Type
  • 3.4.3 Date of International Manufacturers Enter into Testosterone undecanoate Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Testosterone undecanoate Sales by Product
• 4.2 Global Testosterone undecanoate Revenue by Product
• 4.3 Testosterone undecanoate Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Testosterone undecanoate Breakdown Data by End User

6 North America

• 6.1 North America Testosterone undecanoate by Countries
  • 6.1.1 North America Testosterone undecanoate Sales by Countries
  • 6.1.2 North America Testosterone undecanoate Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Testosterone undecanoate by Product
• 6.3 North America Testosterone undecanoate by End User

7 Europe

• 7.1 Europe Testosterone undecanoate by Countries
  • 7.1.1 Europe Testosterone undecanoate Sales by Countries
  • 7.1.2 Europe Testosterone undecanoate Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Testosterone undecanoate by Product
• 7.3 Europe Testosterone undecanoate by End User

8 Asia Pacific

• 8.1 Asia Pacific Testosterone undecanoate by Countries
  • 8.1.1 Asia Pacific Testosterone undecanoate Sales by Countries
  • 8.1.2 Asia Pacific Testosterone undecanoate Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Testosterone undecanoate by Product
• 8.3 Asia Pacific Testosterone undecanoate by End User

9 Central & South America

• 9.1 Central & South America Testosterone undecanoate by Countries
  • 9.1.1 Central & South America Testosterone undecanoate Sales by Countries
  • 9.1.2 Central & South America Testosterone undecanoate Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Testosterone undecanoate by Product
• 9.3 Central & South America Testosterone undecanoate by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Testosterone undecanoate by Countries
  • 10.1.1 Middle East and Africa Testosterone undecanoate Sales by Countries
  • 10.1.2 Middle East and Africa Testosterone undecanoate Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Testosterone undecanoate by Product
• 10.3 Middle East and Africa Testosterone undecanoate by End User

11 Company Profiles

• 11.1 Bayer AG
  • 11.1.1 Bayer AG Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Bayer AG Testosterone undecanoate Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Bayer AG Testosterone undecanoate Products Offered
  • 11.1.5 Bayer AG Recent Development
• 11.2 Endo Pharmaceuticals
  • 11.2.1 Endo Pharmaceuticals Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Endo Pharmaceuticals Testosterone undecanoate Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Endo Pharmaceuticals Testosterone undecanoate Products Offered
  • 11.2.5 Endo Pharmaceuticals Recent Development
• 11.3 Merck Sharp & Dohme
  • 11.3.1 Merck Sharp & Dohme Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Merck Sharp & Dohme Testosterone undecanoate Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Merck Sharp & Dohme Testosterone undecanoate Products Offered
  • 11.3.5 Merck Sharp & Dohme Recent Development
• 11.4 Taro Pharmaceutical
  • 11.4.1 Taro Pharmaceutical Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Taro Pharmaceutical Testosterone undecanoate Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Taro Pharmaceutical Testosterone undecanoate Products Offered
  • 11.4.5 Taro Pharmaceutical Recent Development
• 11.5 Cipla
  • 11.5.1 Cipla Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Cipla Testosterone undecanoate Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Cipla Testosterone undecanoate Products Offered
  • 11.5.5 Cipla Recent Development
• 11.6 Zhejiang Xianju Pharmaceutical
  • 11.6.1 Zhejiang Xianju Pharmaceutical Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Zhejiang Xianju Pharmaceutical Testosterone undecanoate Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Zhejiang Xianju Pharmaceutical Testosterone undecanoate Products Offered
  • 11.6.5 Zhejiang Xianju Pharmaceutical Recent Development
• 11.7 Zhejiang Medicine Co.
  • 11.7.1 Zhejiang Medicine Co. Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Zhejiang Medicine Co. Testosterone undecanoate Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Zhejiang Medicine Co. Testosterone undecanoate Products Offered
  • 11.7.5 Zhejiang Medicine Co. Recent Development

12 Future Forecast

• 12.1 Testosterone undecanoate Market Forecast by Regions
  • 12.1.1 Global Testosterone undecanoate Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Testosterone undecanoate Revenue Forecast by Regions 2019-2025
• 12.2 Testosterone undecanoate Market Forecast by Product
  • 12.2.1 Global Testosterone undecanoate Sales Forecast by Product 2019-2025
  • 12.2.2 Global Testosterone undecanoate Revenue Forecast by Product 2019-2025
• 12.3 Testosterone undecanoate Market Forecast by End User
• 12.4 North America Testosterone undecanoate Forecast
• 12.5 Europe Testosterone undecanoate Forecast
• 12.6 Asia Pacific Testosterone undecanoate Forecast
• 12.7 Central & South America Testosterone undecanoate Forecast
• 12.8 Middle East and Africa Testosterone undecanoate Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Testosterone undecanoate Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.
The global Testosterone undecanoate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Testosterone undecanoate market based on company, product type, end user and key regions.

This report studies the global market size of Testosterone undecanoate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Testosterone undecanoate in these regions.
This research report categorizes the global Testosterone undecanoate market by top players/brands, region, type and end user. This report also studies the global Testosterone undecanoate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.

Market size by Product
Injection
Oral
Market size by End User
Primary hypogonadism
Hypogonadotropic hypogonadism
Late-onset hypogonadism

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Testosterone undecanoate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Testosterone undecanoate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Testosterone undecanoate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Testosterone undecanoate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Testosterone undecanoate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Testosterone undecanoate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.